{"id":"NCT00311376","sponsor":"Allergan","briefTitle":"Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-08","primaryCompletion":"2010-05","completion":"2010-05","firstPosted":"2006-04-06","resultsPosted":"2011-10-17","lastUpdate":"2015-12-04"},"enrollment":416,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Overactive Bladder"],"interventions":[{"type":"BIOLOGICAL","name":"botulinum toxin Type A (200U)","otherNames":["BOTOX速"]},{"type":"BIOLOGICAL","name":"botulinum toxin Type A (300U)","otherNames":["BOTOX速"]},{"type":"OTHER","name":"Normal Saline (Placebo); botulinum toxin Type A (200U)","otherNames":["BOTOX速"]},{"type":"OTHER","name":"Normal Saline (Placebo); botulinum toxin Type A (300U)","otherNames":["BOTOX速"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"OTHER"},{"label":"4","type":"OTHER"}],"summary":"The purpose of this study is to assess the safety and effectiveness of botulinum toxin type A in treating overactive bladder in spinal cord injury or multiple sclerosis patients.","primaryOutcome":{"measure":"Change From Baseline in Number of Weekly Episodes of Urinary Incontinence","timeFrame":"Baseline, Week 6","effectByArm":[{"arm":"Botulinum Toxin Type A (300U)","deltaMin":31.1,"sd":17.02},{"arm":"Botulinum Toxin Type A (200U)","deltaMin":32.3,"sd":22.76},{"arm":"Placebo","deltaMin":28.3,"sd":15.82}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":14,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","France","Germany","New Zealand","Poland","Russia","Slovakia","Ukraine","United Kingdom"]},"refs":{"pmids":["25288099","23892704","22503020"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":30,"n":127},"commonTop":["Urinary tract infection","Urinary retention","Diarrhoea","Pyrexia","Fatigue"]}}